Monthly Archives: August 2020

This UVC Light Device from Dr Sanitize plugs into your Smartphone and Kills COVID-19

Dr Sanitize launches new smartphone-powered UVC light device that kills 99.9% of viruses such as COVID-19.

August 12, 2020 / /

Dr Sanitize has launched a new UVC light device that is powered by your smartphone and kills 99.9% of viruses, germs and bacteria. This UVC light for smartphones kills COVID-19 in seconds without leaving any residue or damaging surfaces. It’s more convenient and effective than typical cleaning sprays, and the size also makes it portable and easy to use on the go.

The UVC light device plugs into the charging port of an iPhone or Android phone which provides it with power. It has many different applications, such as cleansing reusable face masks, mail packages before you open them, door handles, restrooms, car keys and electronic devices. The device is constructed from aluminum and the bulb used is medical grade.

Studies have shown that UVC light for smartphones kills COVID-19. UVC light is also used in the form of in-ceiling lights to cleanse critical laboratory environments. It’s a reliable and well-studied antimicrobial technology that can now be harnessed from a small device that fits on your keychain. The UVC light device from Dr Sanitize is also much cheaper than existing solutions while providing the same benefit in a small and portable package.

For more information or to get in touch with Dr Sanitize, please refer to the contact details below.

Contact: Darren Johnson
Address: 1559 Monmouth Dr. San Diego, CA 92109
Phone: 858-888-6399
Email: info@DrSanitize.com
Web: https://drsanitize.com/

Contact Info:
Name: Darren Johnson
Email: Send Email
Organization: Dr Sanitize
Address: 1559 Monmouth Dr. San Diego, CA 92109
Phone: 858-888-6399
Website: https://drsanitize.com/

Source:

Release ID: 88972490

Rat Blocker Manufacturer Looks For Installer Partnerships Across The UK

The company producing the world’s leading rat blocker product is now on the lookout for installers across the UK interested in partnering with the brand.

August 12, 2020 / /

Rats can become a severe issue for those with commercial or residential buildings. The creatures often make it inside the perimeter by forcing their way through drain pipes and squeezing themselves into the property. However, the straightforward and sleek products from Rat Blockers prevent that from happening.

The inexpensive and environmentally-friendly solutions provided by this company are second to none, and they guarantee to keep rats away and ensure all sewer systems remain in fact and undamaged.

Rat Blockers need partner installers

The company prides itself on trust, teamwork, innovation, responsibility, and putting customers first. They are now on the lookout for installers who wish to become partners and use Rat Blockers products wherever they might fit or maintain drainage systems. Any installer who wants to get in touch and make arrangements with this brand can do so using the contact details at the bottom of this page.

Anyone who works in the industry and deals with drains on a daily basis could benefit from the partnership offer. Firstly, it will assist in making sure there are never any issues with rats creeping into the drains they install. Secondly, teaming up with Rat Blockers will show customers and clients the professional is innovative and uses the latest technology to their advantage.

Rat solutions that last

Rat Blockers offer products that stand the test of time, and so there is no need for installers to replace them every couple of years. Their team understands all the ins and outs of rat infestations, and that is why the product they supply is fit for purpose and solves the issue entirely. More than 95% of all rats that make it into residential and commercial properties come through the drains, and Rat Blockers put a stop to that.

The experts behind this problem-solving brand want to hear from anyone who works with drains professionally who could use the product regularly. They can provide people with all the information and materials they require at specialist rates under the new partnership program.

This is a fantastic opportunity that can’t be missed, and all interested parties need to do is get in touch with the guys from Rat Blockers today. Nobody will regret making that move because it will improve the quality of their services and ensure customers and clients never voice complaints about rats making it through the drainage system and into their home or office.

More information is available from Rat Blockers press contact Brian. To reach the company by phone, call 02081688808, or email at sales@ratblockers.com. Anyone looking to apply can do so via the company website www.ratblockers.com. Rat Blockers postal address is 85 Great Portland St, London, W1W 7LT.

Contact Info:
Name: Brian
Email: Send Email
Organization: Rat Blockers
Address: 85 Great Portland St, London, W1W 7LT.
Phone: 02081688808
Website: https://ratblockers.com/

Source:

Release ID: 88972377

LED & OLED Lighting Products and Displays Market in the Middle East Propelled by Carbon Reduction and Smart Urbanization Initiatives, says Future Market Insights

LED & OLED lighting products and display manufacturers are investing in potential applications for agriculture and intelligent street lighting following government initiatives in the Middle east.

DUBAI, UAE / ACCESSWIRE / August 12, 2020 / Future Market Insights: The Middle Eastern LED & OLED lighting products and displays market is anticipated to cross a US$ 7.1 Bn valuation through the projection period from 2015 to 2025. The covid-19 pandemic has negatively impacted the market owing to a shortage of electronic components owing to production shut down in multiple countries including China. On the other hand, potential disinfection applications with UV LED products will create growth opportunities.

"The Middle-East LED and OLED lighting industry is expected to remain resilient to market fluctuations. Regional governments will help in maintaining stable investments, while private investments will continue to grow, particularly in hospitality sector applications," says the FMI analyst.

For more insights into the Market, Request a Sample of this Report@ https://www.futuremarketinsights.com/reports/sample/rep-eu-1253

LED & OLED Lighting Products and Displays MEA Market – Primary Takeaways

LED lamps are expected to reflect a high growth rate, propelled by demand for alternatives to conventional incandescent lights in the region.
Commercial applications of LED and OLED lighting products and displays are gaining traction, supported by changes in government regulations, and lighting standards.
Saudi Arabia is displaying widespread adoption of LED & OLED lighting products and displays owing development of smart lighting and li-fi systems in the region.

LED & OLED Lighting Products and Displays MEA Market – Growth Factors

Indoor farming, light based wi-fi, and smart sunlight applications are generating niche application opportunities in the middle east.
Major investments from the Gulf Co-operation Council towards industrial and commercial lighting boost market prospects.

LED & OLED Lighting Products and Displays Market – Major Constraints

Higher costs of purchase and installation in comparison to conventional lighting reduces adoption, particularly in rural areas.
Growing competition from linear fluorescent and circadian lighting hurts market prospects.

For information on the Research Approach used in the Report, Request Methodology@ https://www.futuremarketinsights.com/askus/rep-eu-1253

The Projected Impact of Coronavirus

The coronavirus pandemic is likely to result in increasing prices of LED and OLED lighting products and displays in the Middle East. In addition, suspension of production activity in the electronics sector in multiple countries, will hurt supplies of components required to produce LED and OLED lighting products and displays around the globe. However, recent research on UV-based LED products for disinfection applications during the pandemic will generate substantial opportunities for growth within the industry.

Competition Landscape

The Middle East LED & OLED lighting products and displays market comprises players including but not limited to LG Display Co. Ltd., GE Lighting, Zumtobel Group AG, OSRAM Light AG, Toshiba Lighting and Technology Corp., Daktronics Inc., and Barco N.V.

Players in the Middle East LED and OLED lighting products and displays market are pushing for the expansion of production capacities, and product innovations to widen the scope of application to multiple verticals.

For instance, Rexton Technologies has opened the largest LED technologies production facility of the Middle East and North Africa sector in Sharjah. Barco N.V. has unveiled a new range of LED-based video and presentation control systems with 4k technology. OSRAM Light AG has developed a new LED lighting product for automotive applications in dense fog conditions.

Request Special Price for this Report to our Sales Executive@ https://www.futuremarketinsights.com/request-special-price/rep-eu-1253

More About the Study

The FMI study provides detailed insights on LED & OLED lighting products and displays market. The market is broken down in terms of type (solar, conventional, mobile display, consumer TV display, outdoor LED display), and end use (residential and commercial) across two key regions (GCC and Levant).

Explore Future Market Insights Coverage of the Electronics, Semiconductors and ICT Industry

Head Mounted Display Market: Find insights on the head mounted display market with segment analysis, statistics, influencing factors, players and key strategies adopted by market players for a 6-year forecast period.

Russian IT Software and Services Market: FMI's report on the Russian IT software and services market offers details on the market between 2014 -2020. The study covers influencers, revenue sources, market leaders, and strategies.

E-Tailing Solutions Market: Get an in-depth analysis on the e-tailing solutions market with insights on growth levers, opportunities, policies, restraints, regional markets and market leaders.

About Future Market Insights

Expert analysis, actionable insights, and strategic recommendations of the experienced research team at FMI helps clients from across the globe with their unique business intelligence requirements. With a repository of more than thousand reports and 1 million+ data points, the team has studied the electronics, semiconductors, and ICT sector across 50+ countries for over a decade. The team provides unmatched end-to-end research and consulting services. Reach out to explore how we can help.

Contact

Mr. Abhishek Budholiya

Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,

Jumeirah Lakes Towers, Dubai,

United Arab Emirates

MARKET ACCESS DMCC Initiative

For Sales Enquiries: sales@futuremarketinsights.com

For Media Enquiries: press@futuremarketinsights.com

Report: https://www.futuremarketinsights.com/reports/middle-east-led-oled-lighting-products-displays-market

Press Release Source: https://www.futuremarketinsights.com/press-release/middle-east-led-oled-lighting-products-displays-market

SOURCE: Future Market Insights

ReleaseID: 601311

EIA Approved and Exploration Update at Agdz Silver and Copper Project, Morocco

DIDCOT, UK / ACCESSWIRE / August 12, 2020 / Altus Strategies Plc (AIM:ALS)(TSXV:ALTS) (‘'Altus'' or the ‘'Company''), provides an update on the Company's 100% owned Agdz silver and copper project ("Agdz" or the "Project") located 14km southwest of the Bou Skour copper and silver mine in the eastern Anti-Atlas of the Kingdom of Morocco.

Highlights:

Environmental Impact Assessment ("EIA'') approved at Agdz silver and copper project
Approval of Ministry of Interior represents a key milestone in conversion to mining licence
Further silver and copper targets defined by BRGM predictive mapping programme
Previously announced rock chip and grab samples results include:

448 g/t Ag and 4.56 % Cu and 287 g/t Ag and 2.01 % Cu from Makarn Prospect
152 g/t Ag and 4.73 % Cu and 2.96 g/t Au from Daoud Prospect
190 g/t Ag and 1.90 % Cu and 134 g/t Ag and 4.82 % Cu from Amzwaro Prospect
12.90 g/t Ag and 13.05 % Cu from Minière Prospect

Mapping and Induced Polarisation geophysical survey (‘'IP'') to be undertaken

Steven Poulton, Chief Executive of Altus, commented:

"We are pleased to report the successful approval of our Environmental Impact Assessment and baseline study at our Agdz silver and copper project in Morocco. This approval represents a key milestone in the process of converting the current exploration licence into a mining licence.

"Separately, Altus has been working in partnership with the University of Orléans and the BRGM in France to generate new targets based on cutting edge predictive mapping techniques. This work has defined a 1km long, northeast striking priority target in the vicinity of the Makarn Prospect, where sampling by the Company has yielded multiple high-grade silver and copper results, including 448 g/t Ag and 8.0 % Cu from outcrop. This target will be the next priority for our field team to assess, along with the Minière Prospect, where sampling of spoil from historic mine shafts, adits and exploratory pits has returned grades of up to 13.0 % Cu.

"Morocco is highly prospective for the discovery of silver and copper deposits and Agdz is located just 14km from a hard rock silver and copper mine, operated by the Moroccan state mining group Managem. We look forward to advancing Agdz and to updating our shareholders on the resumption of our exploration activities."

Agdz Project: Environmental Impact Assessment

Altus commissioned an independent Moroccan environmental consultancy to undertake the EIA for Agdz. The EIA specifies the baseline environmental conditions and details considerations relevant to a potential conversion of the current exploration permit into a mining licence. The EIA was completed in Q1 2020 and, following public consultation, was accepted and approved by the Ministry of the Interior, Administrator of the Draa Tafilalet Region and Regional Centre of Investment. The approval is valid for a period of five years and is renewable thereafter. Attainment of the approval of an EIA is a key milestone for the granting of a future mining licence and to undertaking mining activities thereafter.

Agdz Project: Priority Prospects

A predictive mapping programme for Agdz was completed at the University of Orléans ‘BRGM Campus' in France. Analysis was undertaken on all surface data compiled by Altus to date, including surface rock and trench results, mapping data and gamma spectrometry and ground magnetic survey results.

The predictive mapping programme was designed to delineate targets in areas of shallow soil cover and where surface weathering or desert varnishing effects may mask the surface expression of mineralisation below. A number of broad targets were identified from the study, encompassing parts of the Amzwaro and Makarn Prospects. One of the priority targets is approximately 1km long and strikes in a north easterly direction in the northern portion of the Makarn Prospect.

The prospects identified at Agdz to date include:

The Amzwaro Prospect: Multiple NNE and NNW trending structures within a zone up to 2km in length and 200m wide, bound by extensional structures. Historical results include rock chip grades of 4.82 % Cu, 189 g/t Ag and 1.91 g/t Au.
The Makarn Prospect: A swarm of mineralised dykes, shears and veins which strike NNE over a distance of 2.8km. Historical results include rock chip grades of 8.00 % Cu and 448 g/t Ag.
The Minière Prospect: A 150m long and 90m wide area of historical underground artisanal mining, exploiting multiple sub-parallel copper bearing zones of alteration. Historical results include rock chip and spoil sample grades of 13.05 % Cu, 12.90 g/t Ag and 0.49 g/t Au.
The Daoud Prospect: A series of NNW striking quartz veins and pervasive silicification, mapped discontinuously over a 700m strike length transected by ENE striking chlorite rich alteration zones. Historical results include rock chip grades of 2.71 % Cu, 152 g/t Ag and 2.96 g/t Au.

Illustrations

The following figures have been prepared and relate to the disclosures in this announcement and are visible in the version of this announcement on the Company's website (www.altus-strategies.com) or in PDF format by following this link: https://altus-strategies.com/site/assets/files/4894/altus_nr_-_agdz_eia_12_aug_2020.pdf

Location of Agdz and Altus' exploration projects in Morocco is shown in Figure 1.
Silver and copper results with key prospects are shown in Figure 2.
Predictive mapping results with priority targets are shown in Figure 3.
Annotated photo of the Minière Prospect is shown in Figure 4.
Selection of photos of Agdz is shown in Figure 5.

Agdz Project: Location

The Company's wholly owned subsidiary, Aterian Resources Limited, has a 100 % interest in the 59.7km2 Agdz Project. The Project comprises four contiguous licence blocks in the Souss-Massa-Drâa region of the Anti-Atlas mountains of central Morocco, approximately 350km south of the capital, Rabat. The Project is approximately 14km southwest of the Bou Skour copper-silver mine and 80km southwest of the world-renowned Imiter silver mine, both operated by the Moroccan mining group Managem. Mineralization hosted on this property is not necessarily indicative of mineralization hosted at Agdz.

The Project is located approximately 35km east of the city of Ouarzazate, where infrastructure and services are of a high standard, including a regional airport. The ‘Noor 1' solar station, which is the world's largest concentrated solar power plant with a planned output of 580 MW is located approximately 40km northwest of Agdz. The Project is accessed via a paved road and a network of unpaved roads and vehicle tracks close to and within the licence.

Agdz Project: Geological setting

Agdz is proximal to the Oued Dar'a Caldera, which formed within a brittle pull apart structure along a northeast trending regional fault zone in the eastern Anti-Atlas. The caldera is located within the highly prospective Neoproterozoic Sidi Flah-Bou Skour inlier of the Saghro Massif, which developed during Pan-African tectonic events. This massif is comprised of a lower tightly folded volcano-sedimentary sequence formed from arc-related metagreywacke and metavolcanics lithologies deposited approximately 650Ma. The lower complex was intruded by diorite, granodiorite and lesser gabbro and monzogranite between 615Ma and 575Ma. The upper complex is comprised predominantly of felsic metavolcaniclastics related to the development of several calderas emplaced typically between 575Ma and 540Ma and is intruded by granitic plutons. The upper complex is gently folded, sitting unconformably on the lower complex. Regionally, ore deposits are commonly associated with the upper complex and are typically spatially related to magmatic emplacement.

The geology at Agdz comprises meta-sedimentary and meta-volcanic sequences. These belong to the upper complex and are cut by a series of sub-parallel NE to NW striking brittle faults and alteration zones, a number of which have been historically mined for copper. The alteration (comprising variably of chlorite, iron, silica, k-feldspar, actinolite, carbonate and barite) is generally located within brittle pull apart fault breccias and fracture zones, between (and oblique to) the mapped lineaments.

Mapping, sampling and ground magnetic surveys undertaken by the Company to date have defined four priority prospects at Agdz namely, Makarn, Amzwaro, Minière and Daoud. The Company has completed a series of 13 reconnaissance trenches at Agdz, totalling 576m in length and excavated to a depth of up to 1m. The trenches have revealed a number of NNE trending alteration zones in packages which are up to 33m wide, beneath a thin cover of soil and float material. Previously reported assay results from 5 of the 13 trenches have been received and reported to date and include 0.65 % Cu and 36.54 g/t Ag over 14.12m and 0.36 % Cu and 13.26 g/t Ag over 13.70m.

Qualified Person

The technical disclosure in this regulatory announcement has been read and approved by Steven Poulton, Chief Executive of Altus. A graduate of the University of Southampton in Geology (Hons), he also holds a Master's degree from the Camborne School of Mines (Exeter University) in Mining Geology. He is a Fellow of the Institute of Materials, Minerals and Mining and has over 20 years of experience in mineral exploration and is a Qualified Person under the AIM rules and NI 43-101.

For further information you are invited to visit the Company's website www.altus-strategies.com or contact:

Altus Strategies Plc
Steven Poulton, Chief Executive
Tel:+44 (0) 1235 511 767
E: info@altus-strategies.com

SP Angel (Nominated Adviser)
Richard Morrison / Soltan Tagiev
Tel: +44 (0) 20 3470 0470

SP Angel (Broker)
Abigail Wayne / Richard Parlons
Tel: +44 (0) 20 3470 0471

Yellow Jersey PR (Financial PR and IR)
Georgia Colkin / Charles Goodwin / Henry Wilkinson
Tel: +44 (0) 20 3004 9512
E: altus@yellowjerseypr.com

About Altus Strategies Plc

Altus Strategies is a London (AIM: ALS) and Toronto (TSX-V: ALTS) listed mining royalty company generating a diversified and precious metal focused portfolio of assets. The Company's focus on Africa and differentiated approach, of generating royalties on its own discoveries as well as through financings and acquisitions with third parties, has attracted key institutional investor backing. The Company engages constructively with all stakeholders, working diligently to minimise its environmental impact and to promote positive economic and social outcomes in the communities where it operates. For further information, please visit www.altus-strategies.com.

Cautionary Note Regarding Forward-Looking Statements

Certain information included in this announcement, including information relating to future financial or operating performance and other statements that express the expectations of the Directors or estimates of future performance constitute "forward-looking statements". These statements address future events and conditions and, as such, involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the statements. Such factors include without limitation the completion of planned expenditures, the ability to complete exploration programmes on schedule and the success of exploration programmes. Readers are cautioned not to place undue reliance on the forward-looking information, which speak only as of the date of this announcement and the forward-looking statements contained in this announcement are expressly qualified in their entirety by this cautionary statement.

Where the Company expresses or implies an expectation or belief as to future events or results, such expectation or belief is based on assumptions made in good faith and believed to have a reasonable basis. The forward-looking statements contained in this announcement are made as at the date hereof and the Company assumes no obligation to publicly update or revise any forward-looking information or any forward-looking statements contained in any other announcements whether as a result of new information, future events or otherwise, except as required under applicable law or regulations.

TSX Venture Exchange Disclaimer

Neither the TSX Venture Exchange nor the Investment Industry Regulatory Organisation of Canada accepts responsibility for the adequacy or accuracy of this release.

Market Abuse Regulation Disclosure

Certain information contained in this announcement would have been deemed inside information for the purposes of Article 7 of Regulation (EU) No 596/2014 ("MAR") until the release of this announcement.

Glossary of Terms
The following is a glossary of technical terms:

"Ag" means silver

"Au" means gold

"BRGM" means the French Bureau de Recherches Géologiques et Minières

‘'Cu'' means copper

"EIA" means Environmental Impact Assessment

"g" means grams

"g/t" means grams per tonne

"grade(s)" means the quantity of ore or metal in a specified quantity of rock

"km" means kilometres

"m" means metres

‘'Ma'' means Mega-annum which is equal to one million years

"NI 43-101" means National Instrument 43-101 "Standards of Disclosure of Mineral Projects of the Canadian Securities Administrators"

"ppm" means parts per million

"Qualified Person" means a person that has the education, skills and professional credentials to act as a qualified person under NI 43-101

SOURCE: Altus Strategies Plc

ReleaseID: 601239

Fiore Gold Continues to Expand Oxide Gold Mineralization at Its Pan Mine, Including 39.6 metres of 0.60 g/t Gold and 16.8 metres of 1.03 g/t Gold

VANCOUVER, BC / ACCESSWIRE / August 12, 2020 / FIORE GOLD LTD. (TSXV:F)(OTCQB:FIOGF) ("Fiore" or the "Company") is pleased to announce the final results from the recently completed drill program at its Pan Mine in Nevada. This drill program is part of a long-term program aimed at expanding the resource and reserve base and extending the mine life.

The seventy-six holes reported here were drilled at several locations around the main North Pan pit, as well as one hole near the smaller Syncline satellite pit (Figure 1). The holes were aimed at expanding the existing oxide resources and reserves both at depth and laterally beyond the current reserve boundaries. In total, 183 holes for a total of 21,741 m (71,330 ft) were drilled as part of the 2019-2020 Pan resource expansion program and all but the last few of these holes will be incorporated in the upcoming resource and reserve estimate. The most recent Proven and Probable reserve estimate from 2018 shows 275,600 gold ounces at an average grade of 0.51 g/t gold (0.015 oz/ton), with reserve cutoff grades of 0.21 g/t gold for the North and satellite pits and 0.14 g/t gold for the South Pit.

Highlights from these seventy-six holes, all from the North Pan area, include:

Hole PR20-089 returned 48.8 metres of 0.40 g/t gold
Hole PR20-092 returned 16.8 metres of 1.03 g/t gold
Hole PR20-095 returned 54.9 metres of 0.43 g/t gold
Hole PR20-121 returned 29.0 metres of 0.53 g/t gold
Hole PR20-132 returned 39.6 metres of 0.60 g/t gold
Hole PR20-137 returned 30.5 metres of 0.50g/t gold
Hole PR20-147 returned 38.1 metres of 0.49 g/t gold
Hole PR20-151 returned 27.4 metres of 0.65 g/t gold

Tim Warman, Fiore's CEO commented, "These holes represent the last of the 140 holes drilled in late 2019 and early 2020 as part of a resource expansion program, and all but the last few of these holes will be included in the resource and reserve update which we expect to complete before the end of September. The updated model will incorporate several previously unrecognized structures that appear to localize higher-grade zones of gold mineralization. These structures were recognized during detailed geological mapping in and around the North and South pits and have been successfully targeted during this most recent round of drilling. Our geological team is already planning the next phase of drilling at Pan which is intended to continue expanding the resource base, test new targets away from the existing pits, and collect PQ core for confirmatory metallurgical testing in the newly identified areas of mineralization."

An initial eight-hole program (PR20-072 to -079) at the Mustang target, located approximately 1,500 m northwest of the Pan North pit, encountered gold mineralization within a low angle structure at the contact between the Pilot shale and the underlying Devils Gate limestone. Five of the eight holes encountered significant gold mineralization, with the best intercepts in PR20-073 with 13.7 m at 0.48 g/t gold and PR20-074 with 10.7 m at 0.62 g/t gold. The Mustang zone will be targeted for follow-up in the next phase of drilling with the goal of defining a mineable resource.

Results

Significant results for the seventy-six holes reported here are shown in the table below. The holes in numeric sequence not shown in the table below were condemnation holes drilled in support of a waste dump expansion:

Hole

From
(m)

To
(m)

Length
(m)

Grade
(g/t Au)

PR20-066

no significant intercepts

PR20-067

79.2

99.1

19.8

0.70

includes

80.8

83.8

3.0

1.46

PR20-068

no significant intercepts

PR20-069

no significant intercepts

PR20-070

13.7

18.3

4.6

0.30

PR20-071

no significant intercepts

PR20-072

45.7

48.8

3.0

1.56

PR20-072

71.6

76.2

4.6

0.41

PR20-073

4.6

18.3

13.7

0.48

PR20-073

27.4

30.5

3.0

0.62

PR20-073

57.9

64.0

6.1

0.28

PR20-074

18.3

19.8

1.5

2.09

PR20-074

56.4

67.1

10.7

0.62

PR20-075

no significant intercepts

PR20-076

73.2

80.8

7.6

0.40

PR20-077

4.6

9.1

4.6

0.50

PR20-077

13.7

16.8

3.0

0.31

PR20-077

29.0

32.0

3.0

1.55

PR20-078

16.8

19.8

3.0

0.44

PR20-079

no significant intercepts

PR20-080

39.6

42.7

3.0

0.44

PR20-081

7.6

12.2

4.6

0.42

PR20-081

21.3

27.4

6.1

0.34

PR20-082

no significant intercepts

PR20-083

no significant intercepts

PR20-084

12.2

19.8

7.6

0.24

PR20-084

25.9

45.7

19.8

0.70

PR20-085

45.7

48.8

3.0

0.24

PR20-086

41.1

45.7

4.6

0.40

PR20-087

35.1

50.3

15.2

0.44

PR20-088

35.1

44.2

9.1

0.24

PR20-089

74.7

96.0

21.3

0.36

PR20-089

111.3

160.0

48.8

0.40

PR20-090

103.6

112.8

9.1

0.28

PR20-090

117.3

125.0

7.6

0.26

PR20-091

44.2

47.2

3.0

0.21

PR20-091

51.8

77.7

25.9

0.34

PR20-092

80.8

102.1

21.3

0.53

PR20-092

114.3

131.1

16.8

1.03

includes

115.8

125.0

9.1

1.48

PR20-093

45.7

50.3

4.6

0.33

PR20-093

80.8

86.9

6.1

0.23

PR20-093

91.4

105.2

13.7

0.27

PR20-094

80.8

106.7

25.9

0.39

PR20-095

0.0

54.9

54.9

0.43

PR20-095

76.2

86.9

10.7

0.36

PR20-096

70.1

85.3

15.2

0.29

PR20-096

94.5

121.9

27.4

0.33

PR20-097

no significant intercepts

PR20-098

53.3

67.1

13.7

0.59

PR20-099

no significant intercepts

PR20-100

no significant intercepts

PR20-103

no significant intercepts

PR20-104

no significant intercepts

PR20-105

no significant intercepts

PR20-106

no significant intercepts

PR20-107

42.7

57.9

15.2

0.99

includes

44.2

50.3

6.1

1.99

PR20-108

no significant intercepts

PR20-109

no significant intercepts

PR20-110

no significant intercepts

PR20-111

no significant intercepts

PR20-112

no significant intercepts

PR20-113

no significant intercepts

PR20-114

no significant intercepts

PR20-115

24.4

30.5

6.1

0.40

PR20-116

no significant intercepts

PR20-117

no significant intercepts

PR20-118

no significant intercepts

PR20-119

no significant intercepts

PR20-120

no significant intercepts

PR20-120

35.1

41.1

6.1

0.72

PR20-121

24.4

53.3

29.0

0.53

includes

30.5

33.5

3.0

1.51

PR20-129

no significant intercepts

PR20-130

39.6

42.7

3.0

0.69

PR20-131

61.0

67.1

6.1

0.67

PR20-131

73.2

93.0

19.8

0.28

PR20-132

42.7

82.3

39.6

0.60

PR20-132

86.9

89.9

3.0

0.23

PR20-132

97.5

109.7

12.2

0.34

PR20-132

155.4

161.5

6.1

0.22

PR20-132

166.1

169.2

3.0

0.25

PR20-133

56.4

86.9

30.5

0.28

PR20-133

91.4

106.7

15.2

0.21

PR20-133

115.8

120.4

4.6

0.36

PR20-134

22.9

56.4

33.5

0.35

PR20-134

74.7

86.9

12.2

0.27

PR20-135

48.8

67.1

18.3

0.35

PR20-136

no significant intercepts

PR20-137

32.0

62.5

30.5

0.50

PR20-138

no significant intercepts

PR20-143

54.9

57.9

3.0

0.56

PR20-144

59.4

65.5

6.1

0.22

PR20-145

no significant intercepts

PR20-146

no significant intercepts

PR20-147

51.8

70.1

18.3

0.34

PR20-147

74.7

112.8

38.1

0.49

PR20-148

56.4

68.6

12.2

0.32

PR20-148

79.2

86.9

7.6

0.61

PR20-149

no significant intercepts

PR20-150

76.2

82.3

6.1

0.45

PR20-150

86.9

94.5

7.6

0.22

PR20-151

48.8

54.9

6.1

0.25

PR20-151

61.0

88.4

27.4

0.65

includes

77.7

82.3

4.6

1.11

PR20-152

65.5

73.2

7.6

0.47

PR20-153

no significant intercepts

PR20-154

47.2

50.3

3.0

0.40

 

 

 

 

 

Figure 2 (cross-section 1) is an southwest to northeast cross-section through the North Pan area that highlights a new zone of thick, shallow gold mineralization centred on the Pilot Shale-Devils Gate Limestone contact that was intersected in a zone between holes PR20-081 and PR20-107. This mineralization is well outside the existing pit-constrained reserve envelope and offers potential to add to the existing resource and reserve base at a relatively low stripping ratio. This cross-section also shows several thick intersections immediately below and between the current North Pan and Red Hill pits.

Figure 3 (cross-section 2) is an east-west section in the same general area as Figure 2, which highlights additional intercepts of oxide gold mineralization at the Pilot-Devils Gate contact below the current reserve pits in holes PR20-67, -150 and -051.

Figure 4 (long-section 3) is an approximately north-south oriented long-section through the North Pit area that highlights newly discovered areas of mineralized Jasperoid breccia north of the North Pit (holes PR20-121 and -147 particularly), as well as another thick zone of strong mineralized along the Pilot-Devil's Gate contact at the south end of the North Pit, that extends well below the base of the current reserve pit (PR20-095, -134 and -135)

Pan Mine Geology

The Pan Mine is a Carlin-style, sedimentary rock-hosted, gold-only deposit, and is comprised of three main zones of mineralization which has currently been traced for over 1,800 m (6,000 feet) along the north-south trending Branham Fault. The North Zone is composed of a large body of silicified solution breccia along the western margin of the Branham fault. Mineralization extends westward from the breccia body along the relatively flat-lying Pilot Shale-Devils Gate Limestone contact. South Pan is largely hosted in strongly clay altered and mineralized solution breccias within the Branham fault zone, and clay altered sediments along the Pilot Shale-Devils Gate Limestone contact which dip to the southeast away from the Branham Fault. Central Pan consist of several smaller pods of mineralization largely along the Pilot Shale-Devils Gate contact along a series of west-northwest trending open folds and north-south secondary faults.

Technical Disclosure

The scientific and technical information relating to Fiore Gold's properties contained in this news release was approved by Paul Noland (AIPG CPG-11293), Fiore Gold's VP Exploration and a "Qualified Person" under National Instrument 43-101.

The reverse circulation (RC) drilling at Pan was performed by Boart Longyear of Salt Lake City, Utah. Down holes surveys were completed by Boart drill crews, supervised by Fiore personnel utilizing a REFLEX north seeking gyroscope. Select holes were surveyed additionally by International Directional Services for quality control. Holes are generally inclined to -65 to -90 degrees below horizontal and drill intersections are reported as drilled thicknesses. The irregular shape of the ore body at Pan make estimations of apparent widths difficult, but true widths are generally within 60% to 90% of the reported downhole intercepts.

Sampling is supervised by Fiore Gold geologists, with samples transported directly to ALS Minerals Lab in Reno, Nevada where samples are prepared, and pulps generated. Samples were assayed for gold by Fire Assay of a 30-gram (1 assay ton) charge with an AA finish, or if over 5.0 g/t were re-assayed and completed with a gravimetric finish. For these samples, the gravimetric data were utilized in calculating gold intersections. All drill samples were also subjected to additional cyanide leach analysis where the sample is treated with a 0.25% NaCN solution and rolled for an hour. An aliquot of the final leach solution is then centrifuged and analyzed by Atomic Absorption Spectroscopy. QA/QC for all drill samples consists of the insertion and continual monitoring of numerous standards and blanks into the sample stream, and the collection of duplicate samples at random intervals within each batch. Selected holes are also analyzed for a 48 multi-element geochemical suite by ICP-MS. ALS Geochemistry-Reno is ISO 17025:2005 Accredited.

Scientific and technical information regarding the Pan Mine resource and reserve estimates referred to herein has been extracted from and is hereby qualified by reference to the technical reports for our projects. The technical reports referenced herein are as follows: (1) the report titled "NI 43-101 Updated Technical Report, Pan Gold Project, White Pine County, Nevada", with an effective date of June 30, 2017, which was prepared by J.B. Pennington, M.Sc., C.P.G., Kent Hartley, P.E., Justin Smith, P.E., RM-SME, and Deepak Malhotra, RM-SME (the "Pan Mine 43-101"), as updated within the Pan Mine Reserve Statement, with an effective date of September 30, 2018, which was prepared by Kent Hartley, P.E., and Justin Smith, P.E., RM-SME.

Corporate Strategy

Our corporate strategy is to grow Fiore Gold into a 150,000 ounce per year gold producer. To achieve this, we intend to:

continue to grow gold production at the Pan Mine, while increasing the resource and reserve base
advance the development of the nearby Gold Rock project
acquire additional production or near-production assets to complement our existing operations

On behalf of FIORE GOLD LTD.

"Tim Warman"

Chief Executive Officer

Contact Us:
info@fioregold.com
1 (416) 639-1426 Ext. 1
www.fioregold.com

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Cautionary Note Regarding Forward Looking Statements

This news release contains "forward-looking statements" and "forward looking information" (as defined under applicable securities laws), based on management's best estimates, assumptions and current expectations. Such statements include but are not limited to, statements regarding, drilling at the Pan Mine, expectations regarding increasing the mineral resources and reserves at the Pan Mine, extending the Pan mine life, that the gold intercepts from the drill results will lead to updated resources and reserves, release of an updated Pan resource and reserve in mid-September 2020, expectations regarding future stripping ratios, ability to leverage Pan Mine infrastructure to assist in the development of Gold Rock, growing gold production at the Pan Mine, goal to become a 150,000-ounce producer, goal to acquire additional production or near production assets, and other statements, estimates or expectations. Often, but not always, these forward-looking statements can be identified by the use of forward-looking terminology such as "expects", "expected", "budgeted", "targets", "forecasts", "intends", "anticipates", "scheduled", "estimates", "aims", "will", "believes", "projects" and similar expressions (including negative variations) which by their nature refer to future events. By their very nature, forward-looking statements are subject to numerous risks and uncertainties, some of which are beyond Fiore Gold's control. These statements should not be read as guarantees of future performance or results. Forward looking statements are based on the opinions and estimates of management at the date the statements are made, as well as a number of assumptions made by, and information currently available to, the Company concerning, among other things, anticipated geological formations, potential mineralization, future plans for exploration and/or development, potential future production, ability to obtain permits for future operations, drilling exposure, and exploration budgets and timing of expenditures, all of which involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievement of Fiore Gold to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Factors that could cause actual results to vary materially from results anticipated by such forward looking statements include, but not limited to, risks related to the Pan Mine performance, risks related to the COVID-19 pandemic, including government restrictions impacting the Company's operations, risks the pandemic poses to its work-force, impacts the virus may have on the ability to obtain services and materials from its suppliers and contractors; the company's limited operating history; risks related to international operations; risks related to general economic conditions, actual results of current or future exploration activities, unanticipated reclamation expenses; changes in project parameters as plans continue to be refined; fluctuations in prices of metals including gold; fluctuations in foreign currency exchange rates; increases in market prices of mining consumables; possible variations in ore reserves, grade or recovery rates; uncertainties involved in the interpretation of drilling results, test results and the estimation of gold resources and reserves; failure of plant, equipment or processes to operate as anticipated; the possibility that capital and operating costs may be higher than currently estimated; the possibility of cost overruns or unanticipated expenses in the work programs; availability of financing; accidents, labour disputes, title disputes, claims and limitations on insurance coverage and other risks of the mining industry; delays in the completion of exploration, development or construction activities; the possibility that required permits may not be obtained on a timely manner or at all; possibility that the Gold Rock Record of Decision will be appealed and that such an appeal may be successful; changes in national and local government regulation of mining operations, tax rules and regulations, and political and economic developments in countries in which Fiore Gold operates, and other factors identified in Fiore Gold's filing with Canadian securities authorities under its profile at www.sedar.com respecting the risks affecting Fiore Gold and its business. Although Fiore Gold has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. The forward-looking statements and forward-looking information are made as of the date hereof and are qualified in their entirety by this cautionary statement. Fiore disclaims any obligation to revise or update any such factors or to publicly announce the result of any revisions to any of the forward-looking statements or forward-looking information contained herein to reflect future results, events or developments, except as require by law. Accordingly, readers should not place undue reliance on forward-looking statements and information.

SOURCE: Fiore Gold Ltd.

ReleaseID: 601267

Canadian Clinical Study Sites Re-Commence Bladder Cancer Study

TORONTO, ON / ACCESSWIRE / August 12, 2020 / Theralase® Technologies Inc. ("Theralase" or "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company dedicated to the research and development of light activated Photo Dynamic Compounds ("PDC") and associated drug formulations, announced today that three out of four of its Canadian clinical study sites have re-commenced new patient enrollment and treatment in the Company's Phase II Non-Muscle Invasive Bladder Cancer ("NMIBC") clinical study ("Study II").

Specifically:

Study Site

Location

Site Status

University Health Network ("UHN")

Toronto, Ontario

Enrolling

London Health Sciences Centre ("LHSC"),

London, Ontario

Enrolling

Nova Scotia Health Authority ("NSHA")

Halifax, Nova Scotia

Enrolling

McGill University Health Centre ("MUHC")

Montreal, Quebec

COVID-19 Hold

On a go forward basis, all future and existing patients to be enrolled and treated (initial and second treatment) in Study II will be treated using the Study II treatment optimizations as communicated via press release on July 30, 2020, specifically:

Bladder volume calculation

Study drug volume calculation

Study device volume calculation

Study device treatment time

Four of the patients previously treated are awaiting second treatment subject to the clinical study site operating room availability. One additional patient is undergoing additional assessments prior to proceeding to second treatment.

The Company is in advanced discussions to launch a number of US based clinical study sites, subject to the United States economy recovering from the COVID-19 pandemic.

The US based Trial Management Organization ("TMO") could potentially launch 4 clinical study sites in 4Q2020 and commence Study II patient enrollment and treatment in 1Q2021.

Shawn Shirazi, Ph.D., Chief Executive Officer of Theralase stated, "Theralase is pleased that 3 out of 4 Canadian clinical study sites are open for new patient enrollment and treatment receiving the new optimized Study II treatment. The clinical data collected on the first twelve patients treated shows a favorable clinical response, which the Company expects will improve due to the implemented Study II treatment optimization."

About Study II

Study II utilizes the Therapeutic Dose (0.70 mg/cm2) of TLD-1433 and is focused on the enrollment and treatment of approximately 100 Bacillus Calmete Guérin ("BCG")-Unresponsive NMIBC patients presenting with Carcinoma In-Situ ("CIS") in approximately 20 clinical study sites located in Canada and the US.

Study II has a:

Primary endpoint of efficacy (defined by Complete Response ("CR")) at any point in time

Secondary endpoint of duration of CR at 360 days post-initial CR (approximately 450 days post initial Study treatment)

Tertiary endpoint of safety measured by incidence and severity of Adverse Events ("AEs") grade 4 or higher that do not resolve within 450 days post-initial treatment

"For single-arm trials of patients with BCG-unresponsive disease, the FDA defines a CR as at least one of the following:

Negative cystoscopy and negative (including atypical) urine cytology

Positive cystoscopy with biopsy-proven benign or low-grade NMIBC and negative cytology

For intravesical therapies without systemic toxicity, the FDA includes, in the definition of a CR, negative cystoscopy with malignant urine cytology, if cancer is found in the upper tract or prostatic urethra and random bladder biopsies are negative.

Intravesical instillation does not deliver the investigational drug to the upper tract or prostatic urethra; therefore, the development of disease in these areas cannot be attributed to a lack of activity of the investigational drug. Thus, sponsors can consider patients with new malignant lesions of the upper tract or prostatic urethra, who have received intravesical therapy to have achieved a CR in the primary analysis; however, sponsors should record these lesions and conduct sensitivity analyses in which these patients are not considered to have achieved a CR."1

About Theralase® Technologies Inc.

Theralase® is a clinical stage pharmaceutical company dedicated to the research and development of light activated Photo Dynamic Compounds and their associated drug formulations intended to safely and effectively destroy various cancers.

Additional information is available at www.theralase.com and www.sedar.com.

Forward Looking Statement:

This news release contains "forward-looking statements" which reflect the current expectations of Company's management for future growth, results of operations, performance, business prospects and opportunities. Such statements include, but are not limited to, statements regarding the Company's proposed development plans with respect to Photo Dynamic Compounds and their drug formulations. Wherever possible, words such as "may", "would", "could", "should", "will", "anticipate", "believe", "plan", "expect", "intend", "estimate", "potential for" and similar expressions have been used to identify these forward-looking statements. These statements reflect management's beliefs with respect to future events and are based on information currently available to management. Forward-looking statements involve significant risks, uncertainties and assumptions; including, with respect to the ability of the Company to: adequately fund, secure the requisite regulatory approvals to commence and successfully complete a Phase II NMIBC clinical study in a timely fashion and implement its commercialization plans. Many factors could cause the Company's actual results, performance or achievements to be materially different from any future results, performance or achievements that may be expressed or implied by such forward-looking statements; including, without limitation, those listed in the filings made by the Company with the Canadian securities regulatory authorities (which may be viewed at www.sedar.com). Should one or more of these risks or uncertainties materialize or should assumptions underlying the forward-looking statements prove incorrect, actual results, performance or achievements may vary materially from those expressed or implied by the forward-looking statements contained in this news release. These factors should be considered carefully, and prospective investors should not place undue reliance on the forward-looking statements. Although the forward-looking statements contained in the press release are based upon what management currently believes to be reasonable assumptions, the Company cannot assure prospective investors that actual results, performance or achievements will be consistent with these forward-looking statements. The Company disclaims any intention or obligation to revise forward-looking statements whether as a result of new information, future developments or otherwise except as required by law. All forward-looking statements are expressly qualified in their entirety by this cautionary statement.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchanges) accepts responsibility for the adequacy or accuracy of this release.

For More Information:

1.866.THE.LASE (843-5273)
416-699-LASE (5273)
www.theralase.com

Kristina Hachey
Chief Financial Officer
khachey@theralase.com
416-699-LASE (5273) x 224

1 "BCG-Unresponsive Nonmuscle Invasive Bladder Cancer: Developing Drugs and Biologics for Treatment – Guidance for Industry" Dated: February 2018

SOURCE: Theralase® Technologies Inc.

ReleaseID: 601214

Portable Oxygen Concentrators Market to Register 7.8% CAGR Through 2026; Sales to Surge as Oxygen Therapy Becomes Crucial in Covid-19 Treatments – Future Market Insights

Portable oxygen concentrator manufacturers are largely concerned with the maintenance of inventories throughout the coronavirus crisis, with optimization of supply chains and distribution channels.

DUBAI, UAE / ACCESSWIRE / August 12, 2020 / Future Market Insights: The portable oxygen concentrators market is projected to reflect a highly promising 7.8% CAGR between the years of forecast from 2016 to 2026. The coronavirus outbreak is characterized by major respiratory symptoms owing to potentially low levels of oxygen in the patient's body. Oxygen therapy is a crucial aspect of Covid-19 treatments, which is expected to strongly support the demand for portable oxygen concentrators throughout the crisis period.

"Portable oxygen concentrators are easy to carry and a number of variants are also approved for applications in airplanes. Coupled with the growing geriatric population and incidences of respiratory disease, the demand for portable oxygen concentrators is likely to continue growing in years to come," states the FMI analyst.

For more insights into the Market, Request a Sample of this Report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-1061

Portable Oxygen Concentrators Market- Critical Takeaways

Pulse flow technologies in portable oxygen concentrators are witnessing increasing demand owing to superior efficacy in treating COPD and other breathing problems.
Home setting applications are contributing significantly to revenue, supported by owing to the trend of miniaturization and easy application of oxygen therapies.
North America remains a leading market for portable oxygen concentrators owing to favorable government initiatives and a vast and widespread geriatric population.

Portable Oxygen Concentrators Market- Drivers

Rising incidences of respiratory ailments such as COPD around the world supports market growth.
Government spending on healthcare infrastructure and geriatric care provides lucrative opportunities.

Portable Oxygen Concentrators Market- Restraints

Strict regulations associated with approval and use of portable oxygen concentrators hinder market growth.
Prohibitory costs of portable oxygen concentrators, and lack of awareness in rural areas restrain adoption rates.

Coronavirus Impact on Portable Oxygen Concentrators Market

With the rapid spread of the coronavirus pandemic, the demand for essential medical equipment has shot up. The potentially severe respiratory symptoms, from poor oxygen levels in the patient's bloodstream will bolster the demand for portable oxygen concentrators. Effective applications in home and hospital settings will contribute to adoption rates and revenue. Manufacturers will remain largely concerned with efforts to optimize supply and distribution channels to circumvent potential challenges from lockdown measures imposed in multiple countries.

For information on the Research Approach used in the Report, Request Methodology@ https://www.futuremarketinsights.com/askus/rep-gb-1061

Competitive Landscape

GCE Group, Koninklijke Philips N.V., O2 Concepts LLC, Inogen Inc., Foshan Keyhub Electronic Industries Co. Ltd., Chart Industries Inc., Oxus America Inc., Resmed Inc., Besco Medical Co., Invacare Corp., Precision Medical Inc., and Drive DeVilbiss Healthcare are some of the leading players in the portable oxygen concentrators market.

Manufacturers in the portable oxygen concentrators market are largely displaying interest in the development and launch of new products to boost functionality and widen their portfolios.

For instance, CAIRE Inc. has unveiled a next generation Freestyle Comfort portable oxygen concentrator with proprietary, self-adjusting functionality. OxygenToGo LLC has entered into a deal to provide Virgin Atlantic with portable oxygen concentrators for use in aircrafts. Similarly, ResMed has unveiled Mobi, a portable oxygen concentrator for COPD patients in the United States.

Ask for Regional Data for the Portable Oxygen Concentrators Market@ https://www.futuremarketinsights.com/ask-regional/rep-gb-1061

About the Study

The study offers readers a comprehensive assessment of the Portable oxygen concentrators market. Global, regional and national-level analysis of the latest trends influencing the portable oxygen concentrators market is covered in this FMI report. The study provides insights according to product (continuous flow portable oxygen concentrator, and pulse flow portable oxygen concentrator), and end user (hospitals, home care, ambulatory surgical center, and travel agents) in seven regions (North America, Latin America, Western Europe, Eastern Europe, Asia Pacific excluding Japan, Japan, and MEA).

Explore FMI's Coverage of the Healthcare, Pharmaceuticals, & Medical Devices Industry

Digital Pathology Market– Get insights on the global digital pathology market through FMI's report covering detailed quantitative and qualitative analysis for projection period 2019-2029.

Healthcare Regulatory Affairs Outsourcing Market– FMI's exhaustive study on the healthcare regulatory affairs outsourcing market covers the latest trends, innovations, key players, and popular strategies for the period 2017-2025.

HDL Cholesterol Kits Market– Obtain detailed analysis on the HDL cholesterol kits market through FMI's report covering competitive analysis, key regions, and segmental analysis.

About Future Market Insights

Expert analysis, actionable insights, and strategic recommendations of the veteran research team at FMI helps clients from across the globe with their unique business intelligence requirements. With a repository of over a thousand reports and 1 million+ data points, the team has scrutinized the healthcare, pharmaceuticals, and medical devices sector across 50+ countries for over a decade. The team provides unmatched end-to-end research and consulting services. Reach out to explore how we can help.

Contact

Mr. Abhishek Budholiya

Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,

Jumeirah Lakes Towers, Dubai,

United Arab Emirates

MARKET ACCESS DMCC Initiative

For Sales Enquiries: sales@futuremarketinsights.com

For Media Enquiries: press@futuremarketinsights.com

Report: https://www.futuremarketinsights.com/reports/portable-oxygen-concentrators-market

Press Release Source: https://www.futuremarketinsights.com/press-release/portable-oxygen-concentrators-market

SOURCE: Future Market Insights

ReleaseID: 601310

EyeGate Pharma Confirms Path Forward with FDA To Develop Combination Product

WALTHAM, MA / ACCESSWIRE / August 12, 2020 / EyeGate Pharmaceuticals, Inc. (NASDAQ:EYEG) ("EyeGate" or "the Company"), a clinical-stage company focused on developing products for treating disorders of the eye, announced today that it has received positive feedback following its pre-IND meeting with the U.S. Food and Drug Administration ("FDA") and has been provided a path forward for the development of MoxiGel, a combination product for the treatment of bacterial conjunctivitis.

The new product will combine EyeGate's Ocular Bandage Gel ("OBG") with an antibiotic that is currently approved for the treatment of bacterial conjunctivitis. EyeGate plans to complete its ongoing pre-clinical work and file an IND for the combination product in the first half of 2021.

About EyeGate

EyeGate is a clinical-stage specialty pharmaceutical company focused on developing and commercializing products for treating diseases and disorders of the eye.

EyeGate's lead product, Ocular Bandage Gel ("OBG"), is based on a modified form of the natural polymer hyaluronic acid. The objective of OBG is to protect the ocular surface in order for the body to re-epithelialize the cornea and improve ocular surface integrity. The product is applied as a clear topical gel, to the damaged ocular surface and possesses unique properties that help hydrate and protect the ocular surface to allow for wound healing. EyeGate is in clinical evaluation for two different patient populations: (1) patients undergoing photorefractive keratectomy ("PRK") surgery to demonstrate corneal wound repair after refractive surgery; and (2) patients with punctate epitheliopathies ("PE") as a result of dry eye to promote reduction of PEs.

For more information, please visit www.EyeGatePharma.com.

EyeGate Social Media

EyeGate uses its website (www.EyeGatePharma.com), Facebook page (https://www.facebook.com/ EyeGatePharma/), corporate Twitter account (https://twitter.com/EyeGatePharma), and LinkedIn page (https://www.linkedin.com/company/135892/) as channels of distribution of information about EyeGate and its product candidates. Such information may be deemed material information, and EyeGate may use these channels to comply with its disclosure obligations under Regulation FD. Therefore, investors should monitor EyeGate's website and its social media accounts in addition to following its press releases, SEC filings, public conference calls, and webcasts. The social media channels that EyeGate intends to use as a means of disclosing the information described above may be updated from time to time as listed on EyeGate's investor relations website.

Forward-Looking Statements

Some of the statements in this press release are "forward-looking" and are made pursuant to the safe harbor provision of the Private Securities Litigation Reform Act of 1995. These "forward-looking" statements include statements relating to, among other things, the commercialization efforts and other regulatory or marketing approval efforts pertaining to EyeGate's products, including EyeGate's OBG product, as well as the success thereof, with such approvals or success may not be obtained or achieved on a timely basis or at all. These statements involve risks and uncertainties that may cause results to differ materially from the statements set forth in this press release, including, among other things, certain risk factors described under the heading "Risk Factors" contained in EyeGate's Annual Report on Form 10-K filed with the SEC on March 4, 2020 or described in EyeGate's other public filings. EyeGate's results may also be affected by factors of which EyeGate is not currently aware. The forward-looking statements in this press release speak only as of the date of this press release. EyeGate expressly disclaims any obligation or undertaking to release publicly any updates or revisions to such statements to reflect any change in its expectations with regard thereto or any changes in the events, conditions or circumstances on which any such statement is based.

Contact

Joseph Green/Laine Yonker
Edison Group for EyeGate Pharmaceuticals
646-653-7030/7035
jgreen@edisongroup.com / lyonker@edisongroup.com

SOURCE: EyeGate Pharmaceuticals, Inc.

ReleaseID: 601268

Jaguar Mining Announces Quarterly Dividend and Decision to Proceed with a Share Consolidation

Board of Directors declares a quarterly cash dividend on common shares
Jaguar intends to consolidate its common shares on a 1 for 10 basis

TORONTO / ACCESSWIRE / August 12, 2020 / Jaguar Mining Inc. ("Jaguar" or the "Company") (TSX:JAG) is pleased to announce that its Board of Directors has declared a dividend of C$0.08 per common share of the Company (a "Share") on a post-Consolidation (as hereinafter defined) basis, payable to shareholders of record at the close of business on the date that is five trading days after the Effective Date (as hereinafter defined) of the Consolidation. Jaguar will make a further announcement to confirm the record date and payable date of the dividend following the completion of the Consolidation.

The Board of Directors intends to review, among other things, the Company's budget, cash flow forecast and existing market conditions on a quarterly basis in order to determine whether any additional dividends will be declared on Shares for subsequent quarters. The declaration, timing, amount and payment of any future dividends remain at the discretion of the Board of Directors. The dividend is designated as an eligible dividend for Canadian income tax purposes.

Jeff Kennedy, Chairman and Director of the Company, stated, "The declaration of a dividend and the concurrent announcement of a share consolidation represent an important milestone for Jaguar as we believe it will create greater exposure for the Company and attract an expanded and diverse group of new institutional and retail investors in the United States, Canada and abroad. The payment of this quarterly dividend also reflects the strong confidence we have in the expected future operating and financial performance of the Company and its mineral properties including the needs of our exploration team in providing for future growth."

The aggregate dollar amount of the dividend contemplated hereby will be paid by the Corporation irrespective of whether the Consolidation is completed.

Announcement of Share Consolidation

The Company also announces that, as previously authorized by its shareholders at the Company's annual general and special meeting of shareholders held on June 5, 2017 and following a determination by its Board of Directors, the Company intends to file articles of amendment implementing a consolidation of its outstanding Shares (the "Consolidation") on the basis of one (1) post-Consolidation Share for every ten (10) pre-Consolidation Shares. On July 17, 2020, the Toronto Stock Exchange (the "TSX") provided the Company with the TSX's conditional approval to proceed with the Consolidation. The Company currently anticipates that, subject to the receipt of all required and final approvals, the Shares will commence trading on the TSX on a post-Consolidation basis under its new CUSIP number 47009M889 (ISINCA47009M8896) beginning at the open of markets on or about August 27, 2020 (the "Effective Date").

It is anticipated that upon completion of the Consolidation, the number of Shares issued and outstanding will be consolidated from 723,502,108 to approximately 72,350,197 on a non-diluted basis, and each shareholder will hold the same percentage of Shares outstanding immediately after the Consolidation as such shareholder held immediately prior to the Consolidation. The exact number of Shares outstanding after the Consolidation will vary based on the elimination of fractional shares. No fractional Shares will be issued in connection with the Consolidation. Rather, all fractions of post-Consolidation Shares will be rounded down to the nearest whole number.

The Consolidation is expected to affect shareholders uniformly, including holders of outstanding securities convertible or exercisable for Shares on the Effective Date, except for minor changes or adjustments resulting from the treatment of fractional shares. On the Effective Date, the exercise prices and the number of Shares issuable upon the exercise or deemed exercise of any warrants, options, deferred share units or other convertible or exchangeable securities of the Company will be automatically proportionately adjusted based on the consolidation ratio to reflect the Consolidation.

The Company believes that the Consolidation may have the effect of, among other things: bolstering the interest of the financial community in the Company and potentially broadening its pool of investors and eligible stock exchanges; improving trading liquidity; and reducing trading commissions and other transaction costs for shareholders.

A letter of transmittal regarding the Consolidation will be mailed to the Company's registered shareholders. All registered shareholders will be required to send their certificate(s) representing pre-Consolidation Shares, along with a properly executed letter of transmittal, to the Company's registrar and transfer agent, TSX Trust Company, in accordance with the instructions provided in the letter of transmittal. Shareholders who hold their Shares through a broker, investment dealer, bank or trust company should contact that nominee or intermediary for their post-Consolidation positions. Until surrendered, each share certificate representing pre-Consolidation Shares will represent the number of whole post-Consolidation Shares to which the holder is entitled as a result of the Consolidation. A copy of the letter of transmittal is posted on the Company's issuer profile on SEDAR at www.sedar.com.

The Company's name and trading symbol will remain unchanged on the TSX as a consequence of the Consolidation, which remains subject to the TSX's final approval.

About Jaguar Mining Inc.

Jaguar Mining Inc. is a Canadian-listed junior gold mining, development, and exploration company operating in Brazil with three gold mining complexes and a large land package with significant upside exploration potential from mineral claims covering an area of approximately 64,000 hectares. The Company's principal operating assets are located in the Iron Quadrangle, a prolific greenstone belt in the state of Minas Gerais and include the Turmalina Gold Mine Complex and Caeté Mining Complex (Pilar and Roça Grande Mines, and Caeté Plant). The Company also owns the Paciência Gold Mine Complex, which has been on care and maintenance since 2012. The Roça Grande Mine has been on temporary care and maintenance since April 2019. Additional information is available on the Company's website at www.jaguarmining.com.

For further information please contact:

Vernon Baker
Chief Executive Officer
Jaguar Mining Inc.
vernon.baker@jaguarmining.com
416-847-1854

Hashim Ahmed
Chief Financial Officer
Jaguar Mining Inc.
hashim.ahmed@jaguarmining.com
416-847-1854

 

Forward-Looking Statements

Certain statements in this news release constitute "forward-looking information" within the meaning of applicable Canadian securities legislation. Forward-looking statements and information are provided for the purpose of providing information about management's expectations and plans relating to the future. All of the forward-looking information made in this news release is qualified by the cautionary statements below and those made in our other filings with the securities regulators in Canada. Forward-looking information contained in forward-looking statements can be identified by the use of words such as "are expected," "is forecast," "is targeted," "approximately," "plans," "anticipates," "projects," "anticipates," "continue," "estimate," "believe" or variations of such words and phrases or statements that certain actions, events or results "may," "could," "would," "might," or "will" be taken, occur or be achieved. All statements, other than statements of historical fact, may be considered to be or include forward-looking information. This news release contains forward-looking information regarding, among other things, the timing, completion and potential benefits of the Consolidation, as well as its potential impact on the Company's shareholder and investor base, and the declaration, timing, amount and payment of potential future dividends. The Company has made numerous assumptions with respect to forward-looking information contained herein, including, among other things, assumptions set forth in the AIF and the Company's most recent management's discussion and analysis, as well as other public disclosure documents that can be accessed under the issuer profile of "Jaguar Mining Inc." on SEDAR at www.sedar.com. Forward-looking information involves a number of known and unknown risks and uncertainties, including among others: the risk of Jaguar not meeting the forecast plans regarding its operations and financial performance; uncertainties with respect to the price of gold, labour disruptions, mechanical failures, increase in costs, environmental compliance and change in environmental legislation and regulation, weather delays and increased costs or production delays due to natural disasters, power disruptions, procurement and delivery of parts and supplies to the operations; uncertainties inherent to capital markets in general (including the sometimes volatile valuation of securities and an uncertain ability to raise new capital) and other risks inherent to the gold exploration, development and production industry, which, if incorrect, may cause actual results to differ materially from those anticipated by the Company and described herein. In addition, there are risks and hazards associated with the business of gold exploration, development, mining and production, including environmental hazards, tailings dam failures, industrial accidents and workplace safety problems, unusual or unexpected geological formations, pressures, cave-ins, flooding, chemical spills, procurement fraud and gold bullion thefts and losses (and the risk of inadequate insurance, or the inability to obtain insurance, to cover these risks). Accordingly, readers should not place undue reliance on forward-looking information.

The forward-looking information set forth herein reflects the Company's reasonable expectations as at the date of this news release and is subject to change after such date. The Company disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, other than as required by law. The forward-looking information contained in this news release is expressly qualified by this cautionary statement.

This news release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the securities in any State in which such offer, solicitation or sale would be unlawful. The securities being offered have not been, nor will they be, registered under the United States Securities Act of 1933, as amended, and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the United States Securities Act of 1933, as amended, and applicable state securities laws.

SOURCE: Jaguar Mining Inc.

ReleaseID: 601227

Inside Benemerito Attorneys at Law: A Look at John Benemerito’s Journey in Helping Start-Up Businesses

NEW YORK, NY / ACCESSWIRE / August 12, 2020 / At only 15 years old, one of the founders and managing partner of Benemerito Attorneys at Law, John Benemerito, already entered into a business venture with his father. Fortunately for him, the business survived throughout his high school, college, and law school years. Since then, John has owned and managed five different businesses while practicing as an attorney-at-law.

Born to a family of entrepreneurs, John has always been a part of their family businesses. He was always well-versed with the challenges of starting and maintaining a business. But other than the business side of things, John was also enamored with the law, which led him to attend law school.

John received his bachelor's degree in criminal justice at John Jay College of Criminal Justice. He then attended New York Law School, where he met Alejandra Gonzalez, a fellow law student who was specializing in commercial real estate and corporate law. After learning more about corporate law, their combined affinity for both business and law in their practice led the two to establish what would now be known as Benemerito Attorneys at Law. They wanted to help aspiring entrepreneurs, and the best way he could do this was by providing their legal assistance.

Like John, Alejandra had a passion for both law and entrepreneurship as well. After finishing her bachelor's degree in communications from the University of Puerto Rico, she moved to New York to pursue her law studies. Right after graduating from law school, she joined John in establishing the law firm.

Both John and Alejandra began their law practice by working with small business owners. Eventually, their legal services expanded to startup businesses. Since then, John and Alejandra have worked side by side with thousands of entrepreneurs from small-scale businesses and startup companies.

Having a strong background in business as he is an entrepreneur himself, John knows the struggles that these startup business owners face. The amount of legal work necessary to comply with business policies can be overwhelming for those who are still starting their businesses. With that in mind, John and Alejandra envisioned a law firm that specializes in the needs of startup companies. Their mission was building a firm around their needs instead of forcing these startup owners to adapt to the legal field.

Benemirito Attorneys at Law is a New York law firm that specializes in business law and securities law. The firm's vision is to provide timely and effective legal services that will, ultimately, help clients meet their needs and achieve their goals.

As a personal mission, John seeks to correct the misconceptions that some entrepreneurs may have about lawyers. He strives to show people that hiring a lawyer does not have to be an expensive experience. Clients may still get high-quality legal services without having to break the bank. This is what the Benemerito law firm seeks to bring in.

With more and more people exploring the business industry, the demand for reliable legal assistance also increases. Many entrepreneurs have no time in their hands to personally take care of the paperwork that is necessary for the business; the rising law firm fills in the gaps for these business owners.

With the law firm being led by an entrepreneur himself, the approach that Benemerito firm takes is more relaxed and designed to give their clients a stress-free experience while fully complying with the legal requirements to help each business reach success. Through his incredible network and team, John has made the firm a one-stop shop for aspiring entrepreneurs who wish to bring their business ideas to life.

For more information about Benemerito Attorneys at Law, visit their official website.

Company: Benemerito Attorneys at Law

Email: info@benemeritolaw.com

Phone number: +1 212 785 1528

Website: BenemeritoLaw.com

SOURCE: Benemerito Attorneys at Law

ReleaseID: 601308